Comparison of effects of treatment with ferrous glycine every day and every other day
Not Applicable
- Conditions
- Anemia.Iron deficiency anemia
- Registration Number
- IRCT20230910059400N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 256
Inclusion Criteria
Women with ferritin level below 35 ng/dl
Women with hemoglobin below 12 g/dl within childbearing years
Menopausal women with hemoglobin below 13 g/dl
Exclusion Criteria
Malignancy
Abnormal uterine bleeding
Systemic diseases such as uncontrolled hypothyroidism and collagen vascular diseases
Unreasonable organomegaly
Absorption deficiencies and unimproved anemias with oral iron treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum hemoglobin. Timepoint: At the starting point of trial , 4 and 12 weeks after treatment. Method of measurement: Complete blood count test.;Serum ferritin. Timepoint: At the starting point of trial , 4 and 12 weeks after treatment. Method of measurement: Ferritin blood test.
- Secondary Outcome Measures
Name Time Method Gastrointestinal side effects such as nausea , constipation and abdominal pain. Timepoint: 4 and 12 weeks after treatment. Method of measurement: Questionnaire.